0001763950 2026-06-12 2026-06-12 0001763950 1 2026-06-12 2026-06-12 iso4217:USD pure shares S-1 S-1 EX-FILING FEES 0001763950 Lantern Pharma Inc. N/A N/A S-1 Lantern Pharma Inc. false Equity Common stock, $0.0001 par value true 2242719 3.90 8746604.10 0.0001381 1207.91 8746604.10 1207.91 0.00 0.00 1207.91 In accordance with Rule 416 under the Securities Act of 1933, as amended (the "Securities Act"), this registration statement shall be deemed to cover an indeterminate number of additional shares of Common Stock to be offered or issued from stock splits, stock dividends or similar transactions. Includes 147,500 shares of the registrant's common stock issuable upon exercise of outstanding warrants, such shares of common stock to be offered and sold by the selling stockholders identified in this registration statement on Form S-1. Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended, on the basis of the average of the high and low prices for a share of the registrant's common stock as reported on the Nasdaq Capital Market on June 9, 2026, which date is a date within five business days of the filing of this registration statement.